TAM
COYA icon

Tucker Asset Management’s Coya Therapeutics COYA Stock Holding History

Tucker Asset Management’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$1.98K – 1692
2024
Q1 		$1.98K Hold
200
– – ﹤0.01% 1314
2023
Q4 		$1.48K Buy
+200
New +$1.11K ﹤0.01% 1186

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tucker Asset Management's COYA Position: Q2 2024 in Review

Tucker Asset Management sold out of Coya Therapeutics (COYA) in Q2 2024, closing a stake of 200 shares — an estimated $1.98K sold.

Tucker Asset Management first reported a position in COYA in Q4 2023 and held it in 2 quarters. The position peaked at $1.98K in Q1 2024. 19 funds tracked by Wall St. Rank hold COYA as of Q2 2024.

  • Tucker Asset Management reported no remaining Coya Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Tucker Asset Management sold 200 Coya Therapeutics shares in Q2 2024, an estimated $1.98K.
  • Tucker Asset Management first reported a position in Coya Therapeutics in Q4 2023 and held it in 2 quarters.
  • Tucker Asset Management's Coya Therapeutics position peaked at $1.98K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2024.

Based on Tucker Asset Management's 13F filing for Q2 2024, filed 9 Aug 2024.